0.05Open0.05Pre Close0 Volume18 Open Interest1.50Strike Price0.00Turnover888.76%IV241.41%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.2686Delta0.6932Gamma9.10Leverage Ratio-0.0154Theta0.0000Rho2.44Eff Leverage0.0002Vega
Sangamo Therapeutics Stock Discussion
Sangamo Therapeutics recently presented critical pre-clinical data on its innovative next-generation integrase technology, the Modular Integrase (MINT) platform, highlighting a significant advancement in the field of genome editing. The announcement came as part of their participation at the 27th Amer...
No comment yet